232 related articles for article (PubMed ID: 22521485)
1. Physiological effects following administration of Citrus aurantium for 28 days in rats.
Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular toxicity of Citrus aurantium in exercised rats.
Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
[TBL] [Abstract][Full Text] [Related]
3. Developmental toxicity of Citrus aurantium in rats.
Hansen DK; Juliar BE; White GE; Pellicore LS
Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):216-23. PubMed ID: 21594979
[TBL] [Abstract][Full Text] [Related]
4. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
[TBL] [Abstract][Full Text] [Related]
5. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
Haller CA; Benowitz NL; Jacob P
Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
[TBL] [Abstract][Full Text] [Related]
7. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and heart rate effects following a single dose of bitter orange.
Bui LT; Nguyen DT; Ambrose PJ
Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
[TBL] [Abstract][Full Text] [Related]
9. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
Kaats GR; Miller H; Preuss HG; Stohs SJ
Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of ergogenic efficacy of energy drinks components (caffeine and bitter orange extract) in combination with alcohol].
Anuchin AM; Iuvs GG
Vopr Pitan; 2014; 83(1):61-6. PubMed ID: 25059058
[TBL] [Abstract][Full Text] [Related]
12. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
13. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
Shara M; Stohs SJ; Mukattash TL
Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
[TBL] [Abstract][Full Text] [Related]
15. Questionable conclusions in the article "Cardiovascular toxicity of Citrus aurantium in exercised rats".
Stohs SJ
Cardiovasc Toxicol; 2013 Jun; 13(2):180-1. PubMed ID: 23568750
[No Abstract] [Full Text] [Related]
16. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
Min B; Cios D; Kluger J; White CM
Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
Shara M; Stohs SJ; Smadi MM
Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
[TBL] [Abstract][Full Text] [Related]
18. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
[TBL] [Abstract][Full Text] [Related]
19. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
20. Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity.
Deshmukh NS; Stohs SJ; Magar CC; Kadam SB
Regul Toxicol Pharmacol; 2017 Nov; 90():318-327. PubMed ID: 28966104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
